Prosecution Insights
Last updated: April 19, 2026

Eit Pharma Inc.

3 pending office actions

Portfolio Summary

3
Total Pending OAs
0
Final Rejections
3
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
17819254 TREATMENT OF CORONAVIRUS INFECTION WITH INTERFERON LAMBDA CARTER, SANDRA DILLAHUNT 1674 Non-Final OA Aug 11, 2022
17760279 TREATMENT OF CORONAVIRUS INFECTION WITH INTERFERON LAMBDA CARTER, SANDRA DILLAHUNT 1674 Non-Final OA Aug 05, 2022
17268657 TREATMENT OF HEPATITIS DELTA VIRUS INFECTION WITH INTERFERON LAMBDA JOSEPH, JANET 1611 Non-Final OA Feb 17, 2021

Managing Eit Pharma Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month